Atea Pharmaceuticals Inc. (AVIR)
NASDAQ · Healthcare
Atea Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2020 to 2021. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Atea Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2021 were 710.1M, a 29.62% increase year-over-year.
- Atea Pharmaceuticals Inc. shareholder equity for 2021 were 710.1M, a 29.62% increase from 2020.
- Atea Pharmaceuticals Inc. shareholder equity for 2020 were 547.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Atea Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2021 | $710 |
| 2020 | $548 |
| Atea Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2021-12-31 | $710 |
| 2020-12-31 | $548 |
Atea Pharmaceuticals Inc. Shareholder Equity — FAQ
Atea Pharmaceuticals Inc. (AVIR) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVIR's shareholder equity history?
The chart and table above show Atea Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.